All Pharma News
Ocumension Shows Strong Resilience And Commercialization Growth

Ocumension Shows Strong Resilience And Commercialization Growth
PR NEWSWIRE
12 Aug 2024
Share Share
OcuMension Acquires Alcon Eye Drops Rights For 16.7% Equity Stake

OcuMension Acquires Alcon Eye Drops Rights For 16.7% Equity Stake
PR NEWSWIRE
12 Aug 2024
Share Share
China approves treatment for chronic non-infectious eye inflammation

China approves treatment for chronic non-infectious eye inflammation
BIOSPECTRUMASIA
23 Jun 2022
Share Share
In a first, China approves eye implant based solely on RWD

In a first, China approves eye implant based solely on RWD
Nick Paul Taylor FIERCEPHARMA
22 Jun 2022
Share Share
Ocumension Therapeutics Announces 2021 Interim Results

Ocumension Therapeutics Announces 2021 Interim Results
PRNEWSWIRE
20 Aug 2021
Share Share
Alimera Sciences Receives $20 Million From Ocumension Therapeutics

Alimera Sciences Receives $20 Million From Ocumension Therapeutics
GLOBENEWSWIRE
14 Apr 2021
Share Share
Ocumension Therapeutics invests $15.7 million in EyePoint Pharmaceuticals

Ocumension Therapeutics invests $15.7 million in EyePoint Pharmaceuticals
PHARMABIZ
04 Jan 2021
Share Share
Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases

Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases
PIPELINEREVIEW
02 Nov 2020
Share Share
Ocumension strengthens pipeline for posterior segment eye diseases in China

Ocumension strengthens pipeline for posterior segment eye diseases in China
BIOSPECTRUMASIA
30 Oct 2020
Share Share
Ocumension strengthens pipeline for posterior segment eye diseases in China

Ocumension strengthens pipeline for posterior segment eye diseases in China
BIOSPECTRUMASIA
30 Oct 2020
Share Share